Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer.
暂无分享,去创建一个
Masoom A Haider | Theodorus H van der Kwast | John Trachtenberg | A. Evans | T. H. van der Kwast | J. Trachtenberg | M. Haider | G. Lockwood | Gina Lockwood | J. Tanguay | A. Hashmi | Andrew J Evans | Jeff Tanguay | Ali-Tahir Hashmi
[1] H. Hricak,et al. Prostate cancer imaging , 2008, Acta radiologica.
[2] Silvia D. Chang,et al. Combined diffusion‐weighted and dynamic contrast‐enhanced MRI for prostate cancer diagnosis—Correlation with biopsy and histopathology , 2006, Journal of magnetic resonance imaging : JMRI.
[3] Thomas Hambrock,et al. Diffusion and perfusion MR imaging of the prostate. , 2008, Magnetic resonance imaging clinics of North America.
[4] T. Stamey,et al. The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. , 1994, The Journal of urology.
[5] K. Macura. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging. , 2008, Seminars in roentgenology.
[6] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[7] A W Partin,et al. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. , 1993, The Journal of urology.
[8] H. Hricak,et al. Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings--initial observations. , 2004, Radiology.
[9] J A Hanley,et al. Extension of receiver operating characteristic analysis to data concerning multiple signal detection tasks. , 1997, Academic radiology.
[10] Gary Liney,et al. Correlation of diffusion‐weighted magnetic resonance data with cellularity in prostate cancer , 2009, BJU international.
[11] B. Issa,et al. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo‐planar imaging , 2002, Journal of magnetic resonance imaging : JMRI.
[12] W Leisenring,et al. A marginal regression modelling framework for evaluating medical diagnostic tests. , 1997, Statistics in medicine.
[13] Thomas Hambrock,et al. Thirty-Two-Channel Coil 3T Magnetic Resonance-Guided Biopsies of Prostate Tumor Suspicious Regions Identified on Multimodality 3T Magnetic Resonance Imaging: Technique and Feasibility , 2008, Investigative Radiology.
[14] K. Hosseinzadeh,et al. Endorectal diffusion‐weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue , 2004, Journal of magnetic resonance imaging : JMRI.
[15] J. Fütterer,et al. Imaging the male reproductive tract: current trends and future directions. , 2008, Radiologic clinics of North America.
[16] L. Fass. Imaging and cancer: A review , 2008, Molecular oncology.
[17] Béla Ágai,et al. CONDENSED 1,3,5-TRIAZEPINES - V THE SYNTHESIS OF PYRAZOLO [1,5-a] [1,3,5]-BENZOTRIAZEPINES , 1983 .
[18] Nacim Betrouni,et al. Computer-assisted diagnosis of prostate cancer using DCE-MRI data: design, implementation and preliminary results , 2008, International Journal of Computer Assisted Radiology and Surgery.
[19] M. Kattan,et al. Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer. , 2005, The Journal of urology.
[20] M. Rifkin,et al. MR imaging characteristics of noncancerous lesions of the prostate , 1992, Journal of magnetic resonance imaging : JMRI.
[21] N. Blumstein,et al. Prostate carcinoma: diffusion-weighted imaging as potential alternative to conventional MR and 11C-choline PET/CT for detection of bone metastases. , 2008, Radiology.
[22] P. Scardino,et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer? , 2004, The Journal of urology.
[23] C. Metz,et al. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously-distributed data. , 1998, Statistics in medicine.
[24] Deanna L Langer,et al. Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2--sparse versus dense cancers. , 2008, Radiology.
[25] Peter Gibbs,et al. Comparison of quantitative T2 mapping and diffusion‐weighted imaging in the normal and pathologic prostate , 2001, Magnetic resonance in medicine.
[26] C. Kim,et al. Localization of Prostate Cancer Using 3T MRI: Comparison of T2-Weighted and Dynamic Contrast-Enhanced Imaging , 2006, Journal of computer assisted tomography.
[27] A. Partin,et al. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. , 1989, The Journal of urology.
[28] William Wells,et al. Detection of prostate cancer by integration of line-scan diffusion, T2-mapping and T2-weighted magnetic resonance imaging; a multichannel statistical classifier. , 2003, Medical physics.
[29] Xavier Leroy,et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings , 2009, European Radiology.
[30] A. Schned,et al. Tissue-shrinkage correction factor in the calculation of prostate cancer volume. , 1996, The American journal of surgical pathology.
[31] P. Carroll,et al. Focal therapy for prostate cancer 1996: maximizing outcome. , 1997, Urology.
[32] Kyung Ah Kim,et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. , 2009, Radiology.
[33] A. D'Amico,et al. Calculated volume of prostate cancer identifies patients with clinical stage T1C disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. , 2000, Urology.
[34] P. Carroll,et al. Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. , 1995, Radiology.
[35] B. K. Park,et al. Lesion Localization in Patients With a Previous Negative Transrectal Ultrasound Biopsy and Persistently Elevated Prostate Specific Antigen Level Using Diffusion-Weighted Imaging at Three Tesla Before Rebiopsy , 2008, Investigative Radiology.
[36] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.